IBDEI067 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6032,1,4,0)
 ;;=4^T82.898D
 ;;^UTILITY(U,$J,358.3,6032,2)
 ;;=^5054954
 ;;^UTILITY(U,$J,358.3,6033,0)
 ;;=N25.81^^39^429^36
 ;;^UTILITY(U,$J,358.3,6033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6033,1,3,0)
 ;;=3^Secondary Hyperparathyroidism of Renal Origin
 ;;^UTILITY(U,$J,358.3,6033,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,6033,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,6034,0)
 ;;=T82.858A^^39^429^37
 ;;^UTILITY(U,$J,358.3,6034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6034,1,3,0)
 ;;=3^Stenosis of Vascular Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,6034,1,4,0)
 ;;=4^T82.858A
 ;;^UTILITY(U,$J,358.3,6034,2)
 ;;=^5054941
 ;;^UTILITY(U,$J,358.3,6035,0)
 ;;=T82.858D^^39^429^38
 ;;^UTILITY(U,$J,358.3,6035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6035,1,3,0)
 ;;=3^Stenosis of Vascular Graft,Subs Encntr
 ;;^UTILITY(U,$J,358.3,6035,1,4,0)
 ;;=4^T82.858D
 ;;^UTILITY(U,$J,358.3,6035,2)
 ;;=^5054942
 ;;^UTILITY(U,$J,358.3,6036,0)
 ;;=T82.868A^^39^429^39
 ;;^UTILITY(U,$J,358.3,6036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6036,1,3,0)
 ;;=3^Thrombosis of Vascular Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,6036,1,4,0)
 ;;=4^T82.868A
 ;;^UTILITY(U,$J,358.3,6036,2)
 ;;=^5054947
 ;;^UTILITY(U,$J,358.3,6037,0)
 ;;=T82.868D^^39^429^40
 ;;^UTILITY(U,$J,358.3,6037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6037,1,3,0)
 ;;=3^Thrombosis of Vascular Graft,Subs Encntr
 ;;^UTILITY(U,$J,358.3,6037,1,4,0)
 ;;=4^T82.868D
 ;;^UTILITY(U,$J,358.3,6037,2)
 ;;=^5054948
 ;;^UTILITY(U,$J,358.3,6038,0)
 ;;=N28.1^^39^430^1
 ;;^UTILITY(U,$J,358.3,6038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6038,1,3,0)
 ;;=3^Cyst of Kidney,Acquired
 ;;^UTILITY(U,$J,358.3,6038,1,4,0)
 ;;=4^N28.1
 ;;^UTILITY(U,$J,358.3,6038,2)
 ;;=^270380
 ;;^UTILITY(U,$J,358.3,6039,0)
 ;;=Q61.9^^39^430^2
 ;;^UTILITY(U,$J,358.3,6039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6039,1,3,0)
 ;;=3^Cystic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,6039,1,4,0)
 ;;=4^Q61.9
 ;;^UTILITY(U,$J,358.3,6039,2)
 ;;=^5018800
 ;;^UTILITY(U,$J,358.3,6040,0)
 ;;=Q61.2^^39^430^6
 ;;^UTILITY(U,$J,358.3,6040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6040,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,6040,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,6040,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,6041,0)
 ;;=Q61.5^^39^430^4
 ;;^UTILITY(U,$J,358.3,6041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6041,1,3,0)
 ;;=3^Medullary Cystic Kidney
 ;;^UTILITY(U,$J,358.3,6041,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,6041,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,6042,0)
 ;;=Z82.71^^39^430^3
 ;;^UTILITY(U,$J,358.3,6042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6042,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,6042,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,6042,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,6043,0)
 ;;=Q61.5^^39^430^5
 ;;^UTILITY(U,$J,358.3,6043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6043,1,3,0)
 ;;=3^Medullary Sponge Kidney
 ;;^UTILITY(U,$J,358.3,6043,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,6043,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,6044,0)
 ;;=Q61.3^^39^430^7
 ;;^UTILITY(U,$J,358.3,6044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6044,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,6044,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,6044,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,6045,0)
 ;;=E11.65^^39^431^11
 ;;^UTILITY(U,$J,358.3,6045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6045,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,6045,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,6045,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,6046,0)
 ;;=E10.65^^39^431^6
 ;;^UTILITY(U,$J,358.3,6046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6046,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,6046,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,6046,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,6047,0)
 ;;=E11.21^^39^431^9
 ;;^UTILITY(U,$J,358.3,6047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6047,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,6047,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,6047,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,6048,0)
 ;;=E10.29^^39^431^3
 ;;^UTILITY(U,$J,358.3,6048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6048,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,6048,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,6048,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,6049,0)
 ;;=E10.21^^39^431^4
 ;;^UTILITY(U,$J,358.3,6049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6049,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,6049,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,6049,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,6050,0)
 ;;=E11.40^^39^431^10
 ;;^UTILITY(U,$J,358.3,6050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6050,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,6050,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,6050,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,6051,0)
 ;;=E10.40^^39^431^5
 ;;^UTILITY(U,$J,358.3,6051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6051,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,6051,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,6051,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,6052,0)
 ;;=E10.22^^39^431^2
 ;;^UTILITY(U,$J,358.3,6052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6052,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,6052,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,6052,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,6053,0)
 ;;=E10.9^^39^431^7
 ;;^UTILITY(U,$J,358.3,6053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6053,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,6053,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,6053,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,6054,0)
 ;;=E11.22^^39^431^8
 ;;^UTILITY(U,$J,358.3,6054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6054,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,6054,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,6054,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,6055,0)
 ;;=E11.9^^39^431^12
 ;;^UTILITY(U,$J,358.3,6055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6055,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,6055,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,6055,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,6056,0)
 ;;=E13.22^^39^431^1
 ;;^UTILITY(U,$J,358.3,6056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6056,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,6056,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,6056,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,6057,0)
 ;;=E83.30^^39^432^26
 ;;^UTILITY(U,$J,358.3,6057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6057,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,6057,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,6057,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,6058,0)
 ;;=E83.31^^39^432^9
 ;;^UTILITY(U,$J,358.3,6058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6058,1,3,0)
 ;;=3^Familial Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,6058,1,4,0)
 ;;=4^E83.31
 ;;^UTILITY(U,$J,358.3,6058,2)
 ;;=^5002998
 ;;^UTILITY(U,$J,358.3,6059,0)
 ;;=E83.51^^39^432^19
 ;;^UTILITY(U,$J,358.3,6059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6059,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,6059,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,6059,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,6060,0)
 ;;=E83.52^^39^432^13
 ;;^UTILITY(U,$J,358.3,6060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6060,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,6060,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,6060,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,6061,0)
 ;;=E87.0^^39^432^16
 ;;^UTILITY(U,$J,358.3,6061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6061,1,3,0)
 ;;=3^Hyperosmolality and Hypernatremia
